Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008)
Каталог · ЕАЭС
Клинические исследования и проекты
Immune Oncology Research Institute · найдено 6
6 исследований
Идёт
Фаза II
Армения
Botensilimab + Balstilimab · Immune Oncology Research Institute
Идёт
Армения
IMMONC0002 · Immune Oncology Research Institute
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
Идёт
Фаза II
Армения
Balstilimab · Immune Oncology Research Institute
Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001)
Идёт
Армения
IMMONC0020 · Immune Oncology Research Institute
Cardiac Angiosarcoma International Registry
Завершено
Фаза III
Армения
Ondansetron; Dexamethasone · Immune Oncology Research Institute
Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone. Can This Modality Improve the Antiemetic Effect
Идёт
Армения
IMMONC0005 · Immune Oncology Research Institute
Rare Embryonal Tumors of the Central Nervous System: International Registry